Pretreatment minimal staging and prognostic factors for non-small cell lung cancer
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 17, S3-S10
- https://doi.org/10.1016/s0169-5002(97)00637-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)The Journal of Thoracic and Cardiovascular Surgery, 1995
- Preoperative staging of non-small-cell carcinoma of the lung: imaging methods.American Journal of Roentgenology, 1995
- Characterization of Chest Masses by FDG Positron Emission TomographyClinical Nuclear Medicine, 1995
- Pretreatment minimal staging for non-small cell lung cancer: an updated consensus reportLung Cancer, 1994
- Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucoseThe Annals of Thoracic Surgery, 1994
- Epidemiology, prognostic factors, and prevention of lung cancerCurrent Opinion in Oncology, 1993
- Prognostic factors in non-small cell lung cancer: a consensus reportLung Cancer, 1991
- Lung cancer biologyCurrent Opinion in Oncology, 1991
- K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the LungNew England Journal of Medicine, 1990
- A New International Staging System for Lung CancerChest, 1986